Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 996,000
-3,000 (-0.30%)
Last updated: Jun 27, 2025
Samsung Biologics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,279,508 | 1,083,316 | 857,691 | 798,056 | 393,589 | 240,975 | Upgrade
|
| Depreciation & Amortization | 619,085 | 599,101 | 489,782 | 308,264 | 161,789 | 143,688 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2,618 | 2,199 | 3,866 | 2,588 | 7,466 | 1,841 | Upgrade
|
| Asset Writedown & Restructuring Costs | 76,927 | 62,655 | - | - | 725.89 | 1,352 | Upgrade
|
| Loss (Gain) From Sale of Investments | -597.28 | -597.28 | -5,152 | -72,653 | -269.12 | -303.96 | Upgrade
|
| Loss (Gain) on Equity Investments | -18,690 | -2,660 | 499.42 | -27,260 | -13,853 | 17,768 | Upgrade
|
| Provision & Write-off of Bad Debts | -1,099 | -6,380 | 21,511 | 22,407 | 4,857 | - | Upgrade
|
| Other Operating Activities | -136,885 | -33,004 | -711.89 | 185,130 | 135,132 | 304.75 | Upgrade
|
| Change in Accounts Receivable | -188,888 | -450,992 | 30,127 | -305,336 | -120,660 | -61,480 | Upgrade
|
| Change in Inventory | -264,743 | -236,200 | -273,896 | -179,912 | -370,571 | -184,885 | Upgrade
|
| Change in Accounts Payable | 117,090 | 409,295 | 267,037 | 134,594 | 21,060 | 58,253 | Upgrade
|
| Change in Unearned Revenue | 203,709 | 10.58 | 27,199 | 44,017 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 364,359 | 232,511 | 248,276 | 43,151 | 235,330 | -15,422 | Upgrade
|
| Operating Cash Flow | 2,052,394 | 1,659,255 | 1,666,229 | 953,048 | 454,596 | 202,090 | Upgrade
|
| Operating Cash Flow Growth | 25.20% | -0.42% | 74.83% | 109.65% | 124.95% | 1890.33% | Upgrade
|
| Capital Expenditures | -1,849,273 | -1,303,573 | -995,071 | -956,840 | -406,254 | -139,665 | Upgrade
|
| Sale of Property, Plant & Equipment | 2,008 | 1,389 | 2,811 | 64.01 | 37.64 | 47.69 | Upgrade
|
| Cash Acquisitions | -601,956 | -601,956 | -1,071,525 | -1,081,821 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -65,053 | -73,952 | -110,254 | -52,386 | -14,898 | -8,901 | Upgrade
|
| Investment in Securities | 435,361 | 734,318 | 607,760 | -1,015,673 | -512,375 | -270,167 | Upgrade
|
| Other Investing Activities | -0 | -0 | -0 | 178.52 | -0 | - | Upgrade
|
| Investing Cash Flow | -2,078,915 | -1,243,776 | -1,566,305 | -3,106,477 | -933,489 | -418,686 | Upgrade
|
| Short-Term Debt Issued | - | 237,000 | 758,500 | 593,750 | 50,000 | 30,000 | Upgrade
|
| Long-Term Debt Issued | - | 892,659 | 45,000 | 211,903 | 648,356 | 499,952 | Upgrade
|
| Total Debt Issued | 1,144,659 | 1,129,659 | 803,500 | 805,653 | 698,356 | 529,952 | Upgrade
|
| Short-Term Debt Repaid | - | -684,500 | -686,783 | -496,988 | -30,000 | -150,000 | Upgrade
|
| Long-Term Debt Repaid | - | -878,947 | -751,967 | -496,906 | -171,734 | -257,392 | Upgrade
|
| Total Debt Repaid | -1,445,961 | -1,563,447 | -1,438,750 | -993,894 | -201,734 | -407,392 | Upgrade
|
| Net Debt Issued (Repaid) | -301,302 | -433,788 | -635,250 | -188,241 | 496,622 | 122,560 | Upgrade
|
| Issuance of Common Stock | - | - | - | 3,200,751 | - | - | Upgrade
|
| Other Financing Activities | - | - | 200 | -12,430 | -0 | 0 | Upgrade
|
| Financing Cash Flow | -301,302 | -433,788 | -635,050 | 3,000,080 | 496,622 | 122,560 | Upgrade
|
| Foreign Exchange Rate Adjustments | 19,802 | 41,593 | 12,245 | -3,242 | 831.1 | -2,215 | Upgrade
|
| Net Cash Flow | -308,021 | 23,284 | -522,882 | 843,409 | 18,560 | -96,251 | Upgrade
|
| Free Cash Flow | 203,120 | 355,682 | 671,158 | -3,792 | 48,343 | 62,425 | Upgrade
|
| Free Cash Flow Growth | -79.59% | -47.01% | - | - | -22.56% | - | Upgrade
|
| Free Cash Flow Margin | 4.15% | 7.82% | 18.17% | -0.13% | 3.08% | 5.36% | Upgrade
|
| Free Cash Flow Per Share | 2853.85 | 4997.36 | 9429.82 | -54.32 | 730.64 | 943.48 | Upgrade
|
| Cash Interest Paid | 58,047 | 62,086 | 63,486 | 33,940 | 18,594 | 15,630 | Upgrade
|
| Cash Income Tax Paid | 465,432 | 307,026 | 319,321 | 188,473 | 42,369 | 38,429 | Upgrade
|
| Levered Free Cash Flow | -707,881 | 55,875 | -446,653 | 21,978 | 62,860 | 41,358 | Upgrade
|
| Unlevered Free Cash Flow | -680,452 | 87,161 | -395,655 | 62,019 | 72,052 | 51,411 | Upgrade
|
| Change in Net Working Capital | 376,112 | -40,552 | 476,162 | -148,213 | 4,403 | 126,702 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.